AptaBio Therapeutics Inc (293780) — Strategic Asset Allocation Index
AptaBio Therapeutics Inc (293780) has a Strategic Asset Allocation Index of 11.7% as of March 2025. Strategic assets (PP&E of ₩6.07 Billion plus long-term investments of ₩-) total ₩6.07 Billion, measured against net assets of ₩51.73 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
AptaBio Therapeutics Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how AptaBio Therapeutics Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of March 2025, the index stands at 11.7%, representing strategic assets of ₩6.07 Billion against net assets of ₩51.73 Billion KRW. Explore how efficiently does AptaBio Therapeutics Inc generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for AptaBio Therapeutics Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for AptaBio Therapeutics Inc from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 293780 stock market capitalisation.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 11.2% | ₩5.85 Billion | ₩5.85 Billion | ₩- | ₩52.37 Billion | ▲ +3.3 pp |
| 2021 | 7.8% | ₩4.82 Billion | ₩4.82 Billion | ₩- | ₩61.67 Billion | ▲ +1.0 pp |
| 2020 | 6.8% | ₩4.89 Billion | ₩4.89 Billion | ₩- | ₩72.04 Billion | ▲ +1.4 pp |
| 2019 | 5.4% | ₩4.03 Billion | ₩4.03 Billion | ₩- | ₩75.16 Billion | ▲ +3.8 pp |
| 2018 | 1.6% | ₩287.09 Million | ₩287.09 Million | ₩- | ₩18.31 Billion | — |